|Market Size in 2022||Market Forecast in 2030||CAGR (in %)||Base Year|
|USD 8.7 Billion||USD 11.5 Billion||9.6%||2022|
Artificial Saliva Market
The global artificial saliva market size was evaluated at $8.7 Billion in 2022 and is slated to hit $11.5 Billion by the end of 2030 with a CAGR of nearly 9.6% between 2023 and 2030.
The market report is an indispensable guide on growth factors, challenges, restraints, and opportunities in the global marketplace. The artificial saliva industry report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, PESTEL analysis, SWOT analysis, Porter’s five force analysis, and value chain analysis. Additionally, the artificial saliva market report explores the investor and stakeholder space to help companies make data-driven decisions.
Artificial saliva is used for the therapeutic management of xerostomia. Moreover, artificial saliva also referred to as saliva alternative made to moisturize the desiccated oral tissues. Furthermore, the physical & biological features of artificial saliva are similar to normal human saliva. In addition to this, artificial saliva is a blend of buffering agents, flavoring agents, and cellulose derivatives. Saliva replacement is accessible as various agents such as mouthwash, liquids, gels, mouthwash, sprays, oils, toothpaste, and chewing gums. Reportedly, artificial saliva provides wetting features that play a major role in protecting oral tissues, improving speech functioning, and eating. Additionally, it minimizes oral cavity irritation caused as a result of liquid.
Rising awareness pertaining to oral hygiene to scale up the global market expansion over 2023-2030
Growing occurrence of dry mouth syndrome or xerostomia causing a reduction in the flow of saliva will propel the growth of the artificial saliva market across the globe. Need for properly maintaining oral hygiene and tooth monitoring will drive the global market trends. Escalating demand for an effective mode of treating dry mouth with either combination therapy or artificial saliva for normalizing the flow of saliva is predicted to expand the scope of the global market demand. Furthermore, artificial saliva stimulating agents have proved to be beneficial in minimizing symptoms related to xerostomia, thereby embellishing the expansion of the market across the globe.
Apart from this, the use of artificial saliva helps in preventing dysphagia and this has culminated into a humungous elevation of the global market. Growing demand for oral sprays, oral gels, and oral liquids by dentists has paved the way for the growth of the global market. High per capita expenditure on oral care items to spearhead the growth of the market globally.
Access to alternative products can decline the growth of the global industry
Easy availability of substitute products for treating dry mouth can impede the growth of the artificial saliva industry across the globe. For instance, there are various number of product substitutes including herbal drugs and salivary stimulants.
Necessity of minimizing dry mouth symptoms to open new growth avenues for the global market
Growing need for reducing the evolution of germs in the mouth along with the necessity of preventing infection of dental cavities will open new avenues of growth for the global artificial saliva market. In addition to this, artificial saliva can help in reducing symptoms of dry mouth, thereby opening new growth opportunities for the global market.
Adverse health effects & allergies due to use of product is a big challenge that can put brakes on the global industry surge
Moreover, side effects related to artificial saliva such as altered speech, digestive issues, and abnormal taste can pose a huge challenge in the growth path of the global artificial saliva industry.
The global artificial saliva market is sectored into product, age group, distribution channel, and region.
In terms of product, the global artificial saliva market is divided into the oral sprays, gels, oral liquids, oral solutions, and powders segments. Furthermore, the oral sprays segment, which accounted for more than one-third of the global market share in 2022, is predicted to retain its domination status even during 2023-2030. The segmental surge in the next eight years can be attributed to the high preference for these products by end-users owing to its user convenience feature and its affordability. Furthermore, oral sprays are easily available to end-users as they do not require a physician’s prescription and are easily available in medical stores. Efficiency and low cost of oral sprays will further boost product penetration across the globe. Moreover, the oral liquids segment is predicted to record the fastest CAGR of about 14.5% over the forecast period and its market attractiveness index of nearly 1.6.
Based on the distribution channel, the global artificial saliva industry is divided into the mail order pharmacies, supermarkets & hypermarkets, retail pharmacies, and hospital pharmacies segments. The mail order pharmacies segment, which dominated the distribution channel landscape in 2022, is predicted to account for a major market share over the forecast timeline. The growth of the segment in the coming years can be due to the easy availability of artificial saliva items in mail order pharmacies. Apart from this, mail order pharmacies provide numerous benefits such as product discounts, personalized customer service, and easy drug refilling.
On the basis of age group, the global artificial saliva market is sectored into adults and pediatric segments.
|Report Attributes||Report Details|
|Report Name||Artificial Saliva Market Research Report|
|Market Size in 2022||USD 8.7 Billion|
|Market Forecast in 2030||USD 11.5 Billion|
|Growth Rate||CAGR of 9.6%|
|Number of Pages||210|
|Key Companies Covered||Biocosmetics Laboratories, Bausch Health Companies Inc., CCMed Ltd, Cipla Ltd., Forward Science, ICPA Health Pvt. Ltd., Fresenius Kabi AG, Mission Pharmacal Company, Perrigo Company PLC, GlaxoSmithKline PLC, Midatech Pharma PLC, and Laboratorios Kin S.A.|
|Segments Covered||By Product, By Age-Group, By Distribution channel, And By Region|
|Regions Covered||North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)|
|Historical Year||2017 to 2021|
|Forecast Year||2023 - 2030|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
North American Artificial Saliva market to register exponential growth over 2023-2030
North America, which accounted for a major revenue share of the global artificial saliva market in 2022, is anticipated to dominate the regional market growth over the forecast timeline. The regional market surge over 2023-2030 can be due to easy access to novel healthcare solutions and innovative artificial saliva items. Apart from this, the high purchasing capacity of consumers in countries such as the U.S. and Canada will proliferate the size of the regional market growth. Rise in the occurrence of Sjogren’s syndrome in the U.S. will further expedite the expansion of the market growth in North America.
On the other hand, the artificial saliva industry in the Asia-Pacific zone is predicted to record the highest gains of 6.3% in the forthcoming years. The regional market expansion over the forecast timespan can be due to a rise in awareness among the population in countries such as China and India pertaining to effective dry mouth treatment modes. Presence of giant players in the region will help in the ascension of the market in the Asia-Pacific zone.
The artificial saliva market profiles key players such as:
By Distribution channel
Artificial saliva is used for the therapeutic management of xerostomia. Moreover, artificial saliva also referred to as saliva alternative is made to moisturize the desiccated oral tissues. Furthermore, the physical & biological features of artificial saliva are similar to normal human saliva. In addition to this, artificial saliva is a blend of buffering agents, flavoring agents, and cellulose derivatives. Saliva replacement is accessible as various agents such as mouthwash, liquids, gels, mouthwash, sprays, oils, toothpaste, and chewing gums.
The global artificial saliva market is projected to expand over 2023-2030 due to the use of artificial saliva helps in preventing dysphagia
According to study, the global artificial saliva market size was $8.7 billion in 2022 and is projected to reach $11.5 billion by the end of 2030.
The global Artificial Saliva market is anticipated to record a CAGR of nearly 9.6% from 2023 to 2030.
The Asia-Pacific artificial saliva industry is set to register the fastest CAGR over the forecasting period subject to a rise in awareness among the population in countries such as China and India pertaining to effective dry mouth treatment modes. Presence of giant players in the region will help in the ascension of the market in the Asia-Pacific zone.
The global artificial saliva market is led by industry players such as Biocosmetics Laboratories, Bausch Health Companies Inc., CCMed Ltd, Cipla Ltd., Forward Science, ICPA Health Pvt. Ltd., Fresenius Kabi AG, Mission Pharmacal Company, Perrigo Company PLC, GlaxoSmithKline PLC, Midatech Pharma PLC, and Laboratorios Kin S.A.